Clinical Trial Update: A Study of AMC6156 in People With Sarcopenia [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports that AMC6156 is being studied for sarcopenia and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Drugs mentioned

• AMC6156

Snippet

Sponsor: Animuscure Inc. | Conditions: Sarcopenia in Elderly, Sarcopenia | Phase 2 | Status: RECRUITING